Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 5964-37-4
2. 26g46g752s
3. 1-propanamine, 2-(1-(4-chlorophenyl)-1-phenylethoxy)-n,n-dimethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
4. 56050-03-4
5. 2-[1-(4-chlorophenyl)-1-phenylethoxy]-n,n-dimethylpropan-1-amine;2-hydroxypropane-1,2,3-tricarboxylic Acid
6. Einecs 227-744-0
7. Unii-26g46g752s
8. Schembl5705589
9. Dtxsid70975034
10. Mecloxamine Citrate [who-dd]
11. Q27254093
12. 2-hydroxypropane-1,2,3-tricarboxylic Acid--2-[1-(4-chlorophenyl)-1-phenylethoxy]-n,n-dimethylpropan-1-amine (1/1)
| Molecular Weight | 510.0 g/mol |
|---|---|
| Molecular Formula | C25H32ClNO8 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 11 |
| Exact Mass | 509.1816447 g/mol |
| Monoisotopic Mass | 509.1816447 g/mol |
| Topological Polar Surface Area | 145 Ų |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 549 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Mecloxamine Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mecloxamine Citrate, including repackagers and relabelers. The FDA regulates Mecloxamine Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mecloxamine Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mecloxamine Citrate supplier is an individual or a company that provides Mecloxamine Citrate active pharmaceutical ingredient (API) or Mecloxamine Citrate finished formulations upon request. The Mecloxamine Citrate suppliers may include Mecloxamine Citrate API manufacturers, exporters, distributors and traders.
click here to find a list of Mecloxamine Citrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Mecloxamine Citrate written confirmation (Mecloxamine Citrate WC) is an official document issued by a regulatory agency to a Mecloxamine Citrate manufacturer, verifying that the manufacturing facility of a Mecloxamine Citrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Mecloxamine Citrate APIs or Mecloxamine Citrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Mecloxamine Citrate WC (written confirmation) as part of the regulatory process.
click here to find a list of Mecloxamine Citrate suppliers with Written Confirmation (WC) on PharmaCompass.
Mecloxamine Citrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mecloxamine Citrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mecloxamine Citrate GMP manufacturer or Mecloxamine Citrate GMP API supplier for your needs.
A Mecloxamine Citrate CoA (Certificate of Analysis) is a formal document that attests to Mecloxamine Citrate's compliance with Mecloxamine Citrate specifications and serves as a tool for batch-level quality control.
Mecloxamine Citrate CoA mostly includes findings from lab analyses of a specific batch. For each Mecloxamine Citrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mecloxamine Citrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Mecloxamine Citrate EP), Mecloxamine Citrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mecloxamine Citrate USP).
LOOKING FOR A SUPPLIER?
